1. Home
  2. HALO vs CACI Comparison

HALO vs CACI Comparison

Compare HALO & CACI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • CACI
  • Stock Information
  • Founded
  • HALO 1998
  • CACI 1962
  • Country
  • HALO United States
  • CACI United States
  • Employees
  • HALO N/A
  • CACI N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • CACI EDP Services
  • Sector
  • HALO Health Care
  • CACI Technology
  • Exchange
  • HALO Nasdaq
  • CACI Nasdaq
  • Market Cap
  • HALO 7.4B
  • CACI 7.3B
  • IPO Year
  • HALO N/A
  • CACI 1979
  • Fundamental
  • Price
  • HALO $50.23
  • CACI $462.02
  • Analyst Decision
  • HALO Buy
  • CACI Buy
  • Analyst Count
  • HALO 9
  • CACI 13
  • Target Price
  • HALO $63.78
  • CACI $502.83
  • AVG Volume (30 Days)
  • HALO 2.6M
  • CACI 378.7K
  • Earning Date
  • HALO 05-06-2025
  • CACI 04-23-2025
  • Dividend Yield
  • HALO N/A
  • CACI N/A
  • EPS Growth
  • HALO 55.40
  • CACI 22.32
  • EPS
  • HALO 3.76
  • CACI 21.19
  • Revenue
  • HALO $1,084,306,000.00
  • CACI $8,361,975,000.00
  • Revenue This Year
  • HALO $24.79
  • CACI $14.55
  • Revenue Next Year
  • HALO $22.65
  • CACI $7.62
  • P/E Ratio
  • HALO $13.36
  • CACI $21.81
  • Revenue Growth
  • HALO 25.64
  • CACI 14.16
  • 52 Week Low
  • HALO $41.28
  • CACI $318.60
  • 52 Week High
  • HALO $70.51
  • CACI $588.26
  • Technical
  • Relative Strength Index (RSI)
  • HALO 34.42
  • CACI 63.98
  • Support Level
  • HALO $58.38
  • CACI $459.26
  • Resistance Level
  • HALO $69.94
  • CACI $483.10
  • Average True Range (ATR)
  • HALO 3.30
  • CACI 13.12
  • MACD
  • HALO -0.27
  • CACI -0.42
  • Stochastic Oscillator
  • HALO 9.30
  • CACI 52.20

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

Share on Social Networks: